Covid-19: See latest data on suppliers and inventory
The unprecedented global outbreak continues as new research has found a shocking immune response to many COVID-19 patients.
In some of the more severe cases, the body’s defense system produces molecules called “autoantibodies” which target genetic material from human cells instead of the virus. The body’s misguided immune response may explain the reason why many survivors have problems months after the initial illness has resolved and the main virus is gone from their bodies.
“It’s not just that these patients have an autoimmune-like immune response,” he (Matthew Woodruff, immunologist at Emory University) said. “It’s that those immune responses are coupled with actual true testable clinical auto-reactivities.”
Researchers are avidly trying to understand and connect how it could be possible to address this problem with how immunologists address other autoimmune diseases such as lupus and rheumatoid arthritis.
New call-to-action
GovShop is dedicated to aiding and partnering with organizations such as the Association for Health Care Resource & Materials Management (AHRMM) of the American Hospital Association through these evolving changes of the pandemic. Keeping buyers and suppliers connected is crucial throughout the changing landscape, and GovShop will continue to share valuable resources for the global community.